APA (7th ed.) Citation

S, M., E, N., Y, B., JA, H., J, S., B, M., . . . LM, S. (2023). Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer. Therapeutic advances in medical oncology, 15, 17588359221146133. https://doi.org/10.1177/17588359221146133

Chicago Style (17th ed.) Citation

S, McLaughlin, et al. "Adjuvant Trastuzumab and Vinorelbine for Early-stage HER2+ Breast Cancer." Therapeutic Advances in Medical Oncology 15 (2023): 17588359221146133. https://doi.org/10.1177/17588359221146133.

MLA (9th ed.) Citation

S, McLaughlin, et al. "Adjuvant Trastuzumab and Vinorelbine for Early-stage HER2+ Breast Cancer." Therapeutic Advances in Medical Oncology, vol. 15, 2023, p. 17588359221146133, https://doi.org/10.1177/17588359221146133.